Incidence of Atrial fibrillation in patient with Permanent pacemaker
DOI:
https://doi.org/10.52206/jsmc.2025.15.1.1060Abstract
Background: Atrial fibrillation (AF) is a common cardiac arrhythmia linked to significant morbidity, particularly in pacemaker patients. Pacemakers, crucial for managing bradycardia and conduction disorders, may increase AF risk, especially in those with dual-chamber devices or conditions like Sick Sinus Syndrome.
Objective: To evaluate the incidence of atrial fibrillation (AF) in patients with permanent pacemakers and identify key predictors of AF.
Materials and Methods: This prospective observational study included 250 patients who received permanent pacemakers between January 2022 and December 2022. AF and atrial high-rate episodes (AHREs) were monitored during the one-year follow-up of patients. Data were collected on patient demographics, pacemaker type, and clinical characteristics. Predictors of AF were identified through logistic regression analysis.
Results: AF was detected in 20% of the patients, with a higher incidence in those with dual-chamber pacemakers (14%) compared to single-chamber devices (6%). An AF risk that was significantly elevated was associated with Sick Sinus Syndrome (OR = 2.50, p = 0.0005). AHRE detection was the strongest predictor of AF (OR = 3.00, p = 0.0001). Age and the type of pacemaker were also significant predictors. These findings highlight the importance of regular monitoring and early intervention in high-risk patients.
Conclusion: The study reveals a substantial risk of AF in pacemaker patients, particularly in those with dual-chamber devices and underlying Sick Sinus Syndrome. Key predictors, such as AHRE detection, advanced age, and pacemaker type, underscore the need for vigilant monitoring and tailored management strategies to improve patient outcomes.
Keywords: Atrial fibrillation, Atrial high-rate episodes, Dual-chamber, Pacemaker, Sick Sinus Syndrome.
References
Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol 2001; 38:1231–65. https://doi.org/10.1016/S0735-1097(01)01587-X
Wolowacz SE, Samuel M, Brennan VK, Jasso-Mosqueda J-G, Van Gelder IC. The cost of illness of atrial fibrillation: a systematic review of the recent literature. Europace 2011;13:1375–85. https://doi.org/10.1093/europace/eur194
Vijapurapu R, Roy A, Demetriades P, Warfield A, Hughes DA, Moon J, et al. Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease. Open Hear 2023; 10:e002316. https://doi.org/10.1136/openhrt-2023-002316
Abedin Z. Incidence of new onset atrial fibrillation in patients with permanent pacemakers and the relation to the pacing mode. Med Sci Monit 2014; 20:268–73. https://doi.org/10.12659/MSM.890052
Doundoulakis I, Gavriilaki M, Tsiachris D, Arsenos P, Antoniou C-K, Dimou S, et al. Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis. Cardiovasc Drugs Ther 2022;36:951–8. https://doi.org/10.1007/s10557-021-07209-8
Arnold M, Richards M, D'Onofrio A, Faulknier B, Gulizia M, Thakur R, et al. Avoiding unnecessary ventricular pacing is associated with reduced incidence of heart failure hospitalizations and persistent atrial fibrillation in pacemaker patients. Europace 2023;25. https://doi.org/10.1093/europace/euad065
Chen JH, Chen GY, Zheng H, Chen QH, Fu FY, Zhang FL, et al. Atrial High-Rate Event Incidence and Predictors in Patients With Permanent Pacemaker Implantation. Front Cardiovasc Med 2021;8. https://doi.org/10.3389/fcvm.2021.728885
Mahmoud MM, Ammar AS, Elsherbiny IAE-M, El-dosouky II. Assessment of Atrial Fibrillation in Patients with Pacemaker Implantation. Egypt J Hosp Med 2022;87:1486–90. https://doi.org/10.21608/ejhm.2022.225436
Moltó-Balado P, Reverté-Villarroya S, Monclús-Arasa C, Balado-Albiol M, Baset-Martínez S, Carot-Domenech J, et al. Heart Failure and Major Adverse Cardiovascular Events in Atrial Fibrillation Patients: A Retrospective Primary Care Cohort Study. Biomedicines 2023;11:18-25. https://doi.org/10.3390/biomedicines11071825
Butt MU, Okumus N, Jabri A, Thomas C, Tarabichi Y, Karim S. Early Versus Late Catheter Ablation of Atrial Fibrillation and Risk of Permanent Pacemaker Implantation in Patients With Underlying Sinus Node Dysfunction. J Am Heart Assoc 2022;11. https://doi.org/10.1161/JAHA.121.023333
LuW-D, Chen J-Y. Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with dual chamber permanent pacemakers: a retrospective study. Sci Rep 2021;11:5753. https://doi.org/10.1038/s41598-021-85301-7
Hwang TH, Yu HT, Kim T-H, Uhm J-S, Kim J-Y, Joung B, et al. Permanent Pacemaker Implantations after Catheter Ablation in Patients with Atrial Fibrillation Associated with Underlying Sinus Node Dysfunction. Korean Circ J. 2020;50: 346. https://doi.org/10.4070/kcj.2019.0268
DeRose JJ, Mancini DM, Chang HL, Argenziano M, Dagenais F, Ailawadi G, et al. Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation. J Am Coll Cardiol 2019;73: 2427–35. https://doi.org/10.1016/j.jacc.2019.02.062
D?bski M, Ulman M, Z?bek A, Boczar K, Haberka K, Kuniewicz M, et al. Permanent atrial fibrillation in patients with a dual-chamber pacemaker. Kardiol Pol 2019;77:1140–6. https://doi.org/10.33963/KP.14974
Lip GYH, Fauchier L, Freedman SB, Van Gelder I, Natale A, Gianni C, et al. Atrial fibrillation. Nat Rev Dis Prim 2016;2:160-16. https://doi.org/10.1038/nrdp.2016.16
Wu Z, Yang L, Shi L, Song H, Shi P, Yang T, et al. Prognostic Impact of Adenosine Receptor 2 (A2aR) and Programmed Cell Death Ligand 1 (PD-L1) Expression in Colorectal Cancer. Biomed Res Int 2019;2019:8014627. https://doi.org/10.1155/2019/8014627
Khan MT, Saadia S, Khan AH, Subhani F, Shafquat A, Saeed Y. Detection of Atrial High-Rate Episodes in Patients with Cardiac Implantable Electronic Devices — a Multicenter Experience from Pakistan: A Cross-Sectional Study. Pak Hear J 2023;56: 43-50. https://doi.org/10.47144/phj.v56i1.2412
Wu I-W, Lin C-Y, Chang L-C, Lee C-C, Chiu C-Y, Hsu H-J, et al. Gut Microbiota as Diagnostic Tools for Mirroring Disease Progression and Circulating Nephrotoxin Levels in Chronic Kidney Disease: Discovery and Validation Study. Int J Biol Sci 2020;16:420–34. https://doi.org/10.7150/ijbs.37421
Kirkham EM, Leis AM, Chervin RD. Weight gain in children after adenotonsillectomy: undesirable weight gain or catch-up growth? Sleep Med 2021;85:147–9. https://doi.org/10.1016/j.sleep.2021.07.010
Sánchez-Recalde Á, Solano-López J, Miguelena-Hycka J, Martín-Pinacho JJ, Sanmartín M, Zamorano JL. COVID-19 and cardiogenic shock. Different cardiovascular presentations with high mortality. Rev Esp Cardiol 2020;73:669–72. https://doi.org/10.1016/j.rec.2020.04.012
Schmaier AA, Schmaier AH. Vascular Disease Patient Information Page: COVID–19-related thrombosis. Vasc Med 2020;25:604–7. https://doi.org/10.1177/1358863X20963804
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
